All Pharma News
J&J`s Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal

J&J`s Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
Eric Sagonowsky FIERCE PHARMA
08 Aug 2023
Share Share
Broad-acting antiviral SARS-CoV-2 drug FYB207 shows longer improved efficacy

Broad-acting antiviral SARS-CoV-2 drug FYB207 shows longer improved efficacy
PHARMIWEB
02 Nov 2022
Share Share
Formycon Publishes Details Of A Previously Undisclosed Pipeline Project – FYB206

Formycon Publishes Details Of A Previously Undisclosed Pipeline Project – FYB206
FORMYCON
19 Sep 2022
Share Share
European Commission approves pharma trio’s Ranivisio

European Commission approves pharma trio’s Ranivisio
John Pinching PHARMATIMES
30 Aug 2022
Share Share
FDA Approves First Biosimilar to Lucentis

FDA Approves First Biosimilar to Lucentis
CONTRACTPHARMA
03 Aug 2022
Share Share
Who’s Hired? Formycon Is Latest To Swap CEO

Who’s Hired? Formycon Is Latest To Swap CEO
David Wallace PHARMAINTELIGENCE
20 May 2022
Share Share
Teva Receives Approval for First Ophthalmology Biosimilar in Europe

Teva Receives Approval for First Ophthalmology Biosimilar in Europe
J. Nutovits LEXBLOG
20 May 2022
Share Share
Formycon &Scientists from TUM publish new Data SARS-CoV-2 FYB207

Formycon &Scientists from TUM publish new Data SARS-CoV-2 FYB207
DGAP
09 Dec 2021
Share Share
DGAP-Adhoc: Formycon Concludes Collaboration and License Agreement with SCG

DGAP-Adhoc: Formycon Concludes Collaboration and License Agreement with SCG
BLOOMBERG
18 Oct 2021
Share Share
Formycon reports on the status of FYB207 development

Formycon reports on the status of FYB207 development
BLOOMBERG
11 Aug 2021
Share Share